Thanks to a partnership with J Lewis Research, healthcare provider Foothill Family Clinic in Salt Lake City, Utah, is conducting two Phase 3 clinical trials for COVID-19 vaccine candidates from both Moderna (mRNA-1273) and Pfizer (BioNTech’s BNT 162). The family-focused health care provider participates as an accountable care organization (ACO) with Utah-based payers and has been caring for Salt Lake City-based residents since 1976.
Foothill Family Clinic Research Partnership
J Lewis Research and Foothill Family Clinic formed a partnership in Salt Lake City to enable patients at the provider to access Phase 2, 3, and 4 clinical trials. Based in Salt Lake City, J Lewis Research conducts many different studies from migraine headaches to meningitis and flu vaccines, and of course, now COVID-19 vaccines from both Moderna and Pfizer. Founded in 1980, J Lewis Research counts from 20 to 40 employees and is still an independent sole proprietorship according to their Linkedin profile.
Focus on At-Risk Individuals
At Foothill Family Clinic, Dr. James Peterson, study investigator, reports, “Now we move on to phase three trials, which are meant to include those...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).